secwatch.observer — SEC 8-K summary
======================================

Issuer:     Liquidia Corp (LQDA)
CIK:        0001819576
Form:       8-K
Filed at:   2022-11-08T23:59:59+00:00
Accession:  0001104659-22-115699
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Liquidia reports Q3 net loss $9.1M; secures key legal wins for YUTREPIA launch
------------------------------------------------------------------------------

- Net loss $9.1M ($0.14/share) vs $7.3M loss in Q3 2021; revenue flat at $3.2M.
- Cash $98.3M as of Sep 30, 2022 vs $57.5M at Dec 31, 2021.
- PTAB ruled '793 patent claims unpatentable; court invalidated '066 patent claims, remaining not infringed; '901 non-infringed.
- Launch of YUTREPIA (treprostinil) likely 12-14 months after PTAB denies rehearing on '793 appeal.
- R&D spend $4.5M flat; G&A up 38% to $6.7M on commercial prep.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819576/000110465922115699/0001104659-22-115699-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819576/000110465922115699/tm2229948d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-115699

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer